DGAP-News

Celesio AG: Celesio sells Irish pharmaceutical wholesale subsidiary to Uniphar

DGAP-News: Celesio AG / Key word(s): Disposal
Celesio AG: Celesio sells Irish pharmaceutical wholesale subsidiary to
Uniphar

14.11.2012 / 07:00

---

Celesio sells Irish pharmaceutical wholesale subsidiary to Uniphar

* Divestment programme concluded faster than planned

Stuttgart, Germany / Dublin, Ireland, 14 November 2012. Celesio sells its
Irish pharmaceutical wholesale subsidiary Cahill May Roberts Ltd (including
Movianto Ireland) to Uniphar, an Irish pharmaceutical wholesale and
logistics company, headquartered in Dublin. The sales price amounts to 49.9
million euro. The transaction is subject to the approval of the relevant
bodies.

Celesio CEO Markus Pinger: ´We will now focus on the Irish pharmacy sector.
With more than 70 pharmacies we have a strong market position which offers
us good growth opportunities.  Therefore, the sale of our Irish wholesale
subsidiary was a logical consequence. At the same time, we have thus
successfully concluded our divestment programme, faster than planned. We
will now focus even more on the future growth projects in context with our
strategic realignment.´

In addition to Cahill May Roberts, Celesio´s divestment programme, which
was started in 2012, included the already completed sales of Movianto
(excluding Movianto Ireland), Pharmexx, the mail-order pharmacy DocMorris
as well as the activities in the Czech Republic.

Press contact
Dr Jens Schreiber, Celesio AG, +49 (0)711.5001-380
[e-mail]

Rainer Berghausen, Celesio AG, +49 (0)711.5001-549  
[e-mail]

About Celesio Group
As a leading international trading company and provider of logistics and
services in the pharmaceutical and healthcare sector, Celesio takes a
proactive and preventive approach to ensuring that patients receive the
products and support that they require for optimum care. We operate in 18
countries around the world and have about 41,000 employees. Every day, we
serve over 2 million customers - at 2,200 pharmacies of our own and 4,500
participants in our brand partnership schemes. With around 140 wholesale
branches, we supply approximately 65,000 pharmacies and hospitals every day
with up to 130,000 pharmaceutical products. Our services benefit a patient
pool of about 15 million per day.

End of Corporate News

---

14.11.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP´s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:    English                                                    
Company:     Celesio AG                                                 
             Neckartalstr. 155                                          
             70376 Stuttgart                                            
             Germany                                                    
Phone:       [phone]                                        
Fax:         [phone]                                        
E-mail:      [e-mail]                                       
Internet:    www.celesio.com                                            
ISIN:        DE000CLS1001                                               
WKN:         CLS100                                                     
Indices:     MDAX                                                       
Listed:      Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime  
             Standard), München, Stuttgart; Freiverkehr in Hamburg,      
             Hannover; Terminbörse EUREX                                

End of News    DGAP News-Service  

---

  
193102 14.11.2012